Design of fine particles for pulmonary drug delivery

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Expert Opinion on Drug Delivery

• Publication date

  2007-05-01

• Fields of study

  Medicine, Materials Science, Engineering

• Identifiers
  DOI 10.1517/17425247.4.3.297PMID 17489656
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Delivery Systems for Pulmonary Gene Therapy

  2012cited by this paper
• Recent Advances in the Development of an Inhaled Insulin Product

  2012cited by this paper
• Particle Engineering for Pulmonary Drug Delivery

  2007cited by this paper
• Inhaled Insulin is Better Absorbed When Administered as a Dry Powder Compared to Solution in the Presence or Absence of Alkylglycosides

  2006influential reference
• Particulate nanomedicines.

  2006cited by this paper
• Ultrafine Particle–Lung Interactions: Does Size Matter?

  2006cited by this paper
• In situ coating--an approach for particle modification and encapsulation of proteins during spray-drying.

  2006cited by this paper
• Inhalation aerosols : physical and biological basis for therapy

  2006cited by this paper
• Manufacture, Characterization, and Pharmacodynamic Evaluation of Engineered Ipratropium Bromide Particles

  2006cited by this paper
• Degree of Throat Deposition Can Explain the Variability in Lung Deposition of Inhaled Drugs

  2006cited by this paper
• Particle engineering techniques for inhaled biopharmaceuticals.

  2006cited by this paper
• Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin.

  2006cited by this paper
• The Expanding Role of Aerosols in Systemic Drug Delivery, Gene Therapy, and Vaccination

  2005cited by this paper
• Dry Powder Inhaler Formulation

  2005cited by this paper
• Carrier-based strategies for targeting protein and peptide drugs to the lungs

  2005cited by this paper
• Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery.

  2005cited by this paper
• Medical devices for the delivery of therapeutic aerosols to the lungs

  2005cited by this paper
• SCF-engineered powders for delivery of budesonide from passive DPI devices.

  2005cited by this paper
• Expression and Transport Functionality of FcRn within Rat Alveolar Epithelium: A Study in Primary Cell Culture and in the Isolated Perfused Lung

  2005cited by this paper
• Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles

  2005cited by this paper
• Chitosan oligomers as potential and safe absorption enhancers for improving the pulmonary absorption of interferon-alpha in rats.

  2005cited by this paper
• EXUBERA®: Pharmaceutical Development of a Novel Product for Pulmonary Delivery of Insulin

  2005influential reference
• Dose response of inhaled dry-powder insulin and dose equivalence to subcutaneous insulin lispro.

  2005cited by this paper
• Oral and pulmonary delivery of FSH-Fc fusion proteins via neonatal Fc receptor-mediated transcytosis.

  2005cited by this paper
• Delivery of an Erythropoietin-Fc Fusion Protein by Inhalation in Humans through an Immunoglobulin Transport Pathway

  2005cited by this paper
• Novel hydrofluoroalkane suspension formulations for respiratory drug delivery

  2005cited by this paper
• Generation of fibrous aerosols from thin films

  2005cited by this paper
• Aqueous two-phase systems as a formulation concept for spray-dried protein.

  2005cited by this paper
• Dose Delivery Characteristics of the AIR® Pulmonary Delivery System Over a Range of Inspiratory Flow Rates

  2005influential reference
• Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI.

  2005cited by this paper
• Evaluation of immunogenicity and side effects of triple viral vaccine (MMR) in adults, given by two routes: subcutaneous and respiratory (aerosol).

  2005cited by this paper
• Rational design of solid aerosols for immunoglobulin delivery by modulation of aerodynamic and release characteristics.

  2004influential reference
• Pulmonary Delivery of Low Molecular Weight Heparins

  2004influential reference
• Optimisation of powders for pulmonary delivery using supercritical fluid technology.

  2004cited by this paper
• DESIGNING STABLE AND HIGH PERFORMANCE RESPIRABLE PARTICLES OF PHARMACEUTICALS

  2004influential reference
• Alternative sugars as potential carriers for dry powder inhalations.

  2004influential reference
• Preparation of Large Porous Deslorelin-PLGA Microparticles with Reduced Residual Solvent and Cellular Uptake Using a Supercritical Carbon Dioxide Process

  2004cited by this paper
• Vaccines for the prevention of diseases caused by potential bioweapons.

  2004cited by this paper
• The Cohesive-Adhesive Balances in Dry Powder Inhaler Formulations I: Direct Quantification by Atomic Force Microscopy

  2004cited by this paper
• Dry powder inhalers for pulmonary drug delivery

  2004cited by this paper
• Spray-Drying of a Cohesive Material for Pulmonary Delivery

  2004cited by this paper
• Characterization of Suspension-Based Metered Dose Inhaler Formulations Composed of Spray-Dried Budesonide Microcrystals Dispersed in HFA-134a

  2004influential reference
• Physical stability of salmon calcitonin spray-dried powders for inhalation.

  2004influential reference
• Absorption enhancers in pulmonary protein delivery.

  2004cited by this paper
• The Cohesive-Adhesive Balances in Dry Powder Inhaler Formulations II: Influence on Fine Particle Delivery Characteristics

  2004cited by this paper
• Pulmonary Delivery of Salmon Calcitonin Dry Powders Containing Absorption Enhancers in Rats

  2004cited by this paper
• Insulin Nanoparticles: A Novel Formulation Approach for Poorly Water Soluble Zn-Insulin

  2004cited by this paper
• Current strategies for engineering drug nanoparticles

  2004cited by this paper
• Local and Systemic Immune Responses to Intratracheal Instillation of Antigen and DNA Vaccines in Mice

  2004cited by this paper
• Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway.

  2004cited by this paper
• A novel spray-drying technique to produce low density particles for pulmonary delivery.

  2004cited by this paper
• Influenza vaccine powder formulation development: spray-freeze-drying and stability evaluation.

  2004influential reference
• Pulmonary Delivery of Deslorelin: Large-Porous PLGA Particles and HPβCD Complexes

  2004cited by this paper
• Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung.

  2004cited by this paper
• Feasibility of preparing nanodrugs by high-gravity reactive precipitation.

  2004cited by this paper
• Preparation of griseofulvin nanoparticles from water-dilutable microemulsions.

  2003cited by this paper
• Inhalation of a dry powder tobramycin PulmoSphere formulation in healthy volunteers.

  2003influential reference
• Feasibility of Aerosol Vaccination in Humans

  2003cited by this paper
• Microcalorimetric Measurement of the Interactions Between Water Vapor and Amorphous Pharmaceutical Solids

  2003cited by this paper
• Evaluation of novel aerosol formulations designed for mucosal vaccination against influenza virus.

  2003cited by this paper
• The global burden of measles in the year 2000--a model that uses country-specific indicators.

  2003cited by this paper
• Chemical Processing and Micromixing in Confined Impinging Jets

  2003cited by this paper
• Comparison of Shelf-Life Estimates for a Human Insulin Pharmaceutical Preparation Using the Matrix and Full-Testing Approaches

  2003cited by this paper
• Release mechanism of insulin encapsulated in trehalose ester derivative microparticles delivered via inhalation.

  2003cited by this paper
• Nanosizing: a formulation approach for poorly-water-soluble compounds.

  2003cited by this paper
• Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagle dogs.

  2003cited by this paper
• Ultrafine Particle Deposition in Humans During Rest and Exercise

  2003cited by this paper
• Enhanced immunogenicity of a hepatitis B virus peptide vaccine using oligosaccharide ester derivative microparticles.

  2002cited by this paper
• Gene Therapy Progress and Prospects: Cystic fibrosis

  2002cited by this paper
• Technosphere™/Insulin—A New Approach for Effective Delivery of Human Insulin Via the Pulmonary Route

  2002cited by this paper
• Improved Lung Delivery from a Passive Dry Powder Inhaler Using an Engineered PulmoSphere® Powder

  2002influential reference
• Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren.

  2002cited by this paper
• In Vivo Lung Deposition of Hollow Porous Particles from a Pressurized Metered Dose Inhaler

  2002influential reference
• Liquid ventilation with perflubron in the treatment of rats with pneumococcal pneumonia

  2002influential reference
• Characterization of a surface modified dry powder inhalation carrier prepared by “particle smoothing”

  2002cited by this paper
• Pulmonary Insulin Administration Using the AERx® Insulin Diabetes System

  2002cited by this paper
• In vitro and in vivo dose delivery characteristics of large porous particles for inhalation.

  2002influential reference
• Physical Properties of Supercritically-Processed and Micronised Powders for Respiratory Drug Delivery

  2002cited by this paper
• Dry Powders for Pulmonary Delivery of Peptides and Proteins

  2002cited by this paper
• Monoklonale Antikörper zur Therapie¹

  2001cited by this paper
• Liquid Dose Pulmonary Instillation of Gentamicin PulmoSpheres® Formulations: Tissue Distribution and Pharmacokinetics in Rabbits

  2001influential reference
• Facilitation of Pulmonary Insulin Absorption by H-MAP: Pharmacokinetics and Pharmacodynamics in Rats

  2001cited by this paper
• Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.

  2001cited by this paper
• Receptor-Mediated Targeting of Spray-Dried Lipid Particles Coformulated with Immunoglobulin and Loaded with a Prototype Vaccine

  2001cited by this paper
• Dry powders of stable protein formulations from aqueous solutions prepared using supercritical CO(2)-assisted aerosolization.

  2001influential reference
• Lactose as a carrier in dry powder formulations: the influence of surface characteristics on drug delivery.

  2001cited by this paper
• Novel Lipid-Based Hollow-Porous Microparticles as a Platform for Immunoglobulin Delivery to the Respiratory Tract

  2000cited by this paper
• Pulmonary effects of inhaled ultrafine particles

  2000cited by this paper
• Hollow Porous Particles in Metered Dose Inhalers

  2000influential reference
• Supercritical and Near-critical Carbon Dioxide Assisted Low-Temperature Bubble Drying

  2000influential reference
• Stabilization and Delivery of Labile Materials by Amorphous Carbohydrates and Their Derivatives

  2000influential reference
• Sustained Release Drug Delivery to the Lungs

  2000cited by this paper
• Therapeutic monoclonal antibodies.

  2000cited by this paper
• Respirable PLGA Microspheres Containing Rifampicin for the Treatment of Tuberculosis: Manufacture and Characterization

  2000cited by this paper
• Thermomechanical properties of amorphous saccharides: their role in enhancing pharmaceutical product stability.

  1999cited by this paper
• Formulation and Physical Characterization of Large Porous Particles for Inhalation

  1999cited by this paper
• Large Porous Particles for Sustained Protection from Carbachol-Induced Bronchoconstriction in Guinea Pigs

  1999cited by this paper
• Inhalation of Estradiol for Sustained Systemic Delivery

  1999cited by this paper
• Strategies for particle design using supercritical fluid technologies.

  1999cited by this paper
• The Effect of Formulation Excipients on Protein Stability and Aerosol Performance of Spray-Dried Powders of a Recombinant Humanized Anti-IgE Monoclonal Antibody1

  1999cited by this paper

• Design of Dry Powder Inhalers: 1. Does Size Matter?

  2026cites this paper
• Solid solubility measurement and microparticle production by supercritical process: A case study of pirfenidone

  2026cites this paper
• Recent approaches of proliposome-based dry powder inhalation for pulmonary delivery

  2026cites this paper
• Preparation, characterisation and pharmacokinetics evaluation of dry power inhalation formulations of polymyxin B

  2025cites this paper
• Electrosprayed co-crystals of levofloxacin for inhalation: a strategy for excipient-free dry powder antibiotics.

  2025cites this paper
• Spray-Drying Process Optimization and Modeling for an Inhaled Dry Powder of 5‑Azacytidine for Treating Local and Metastatic Lung Cancer

  2025cites this paper
• Comprehensive analysis of spray drying process variables to improve microparticle properties for effective lung delivery

  2025cites this paper
• Optimization, In Vitro, and In Silico Characterization of Theophylline Inhalable Powder Using Raffinose-Amino Acid Combination as Fine Co-Spray-Dried Carriers

  2025cites this paper
• Development and Evaluation of Hydrophilic Polymer- Integrated Curcuminoid Nanoparticles for Improved Dissolution Rates

  2025cites this paper
• Developing Dry Powder Inhaler Formulations

  2024cites this paper
• Influence of L-leucine content on the aerosolization stability of spray-dried protein dry powder inhalation (DPI).

  2024cites this paper
• Encapsulation of Nanocrystals in Mannitol-Based Inhalable Microparticles via Spray-Drying: A Promising Strategy for Lung Delivery of Curcumin

  2024cites this paper
• Respiratory delivered vaccines: Current status and perspectives in rational formulation design

  2024cites this paper
• Detection of Excipient–Excipient Interaction in Dry Powder Inhaler Formulation Prepared by Spray Drying

  2024cites this paper
• Emerging application of nanomedicine-based therapy in acute respiratory distress syndrome.

  2024cites this paper
• Elucidation of the using condition and working mechanism of tertiary lactose in dry powder formulations for inhalation

  2023cites this paper
• Customizable Resveratrol Spray-dried Micro-composites for Inhalation as a Promising Contender for Treatment of Idiopathic Pulmonary Fibrosis.

  2023cites this paper
• Recent advances in respiratory immunization: A focus on COVID-19 vaccines

  2023cites this paper
• The future of dry powder inhaled therapy: Promising or discouraging for systemic disorders?

  2022cites this paper
• Dextran Mass Ratio Controls Particle Drying Dynamics in a Thermally Stable Dry Powder Vaccine for Pulmonary Delivery

  2022cites this paper
• Spray-dried Pneumococcal Membrane Vesicles are Promising Candidates for Pulmonary Immunization.

  2022cites this paper
• Half a Century of Technological Advances in Pulmonary Drug Delivery: A Personal Perspective

  2022cites this paper
• Pharmacokinetics of rifampicin after repeated intra-tracheal administration of amorphous and crystalline powder formulations to Sprague Dawley rats.

  2021cites this paper
• Bridging micro/nano-platform and airway allergy intervention.

  2021cites this paper
• A meticulous overview on drying-based (spray-, freeze-, and spray-freeze) particle engineering approaches for pharmaceutical technologies

  2021cites this paper
• Influence of microbubbles on the production of spray-dried inhalable particles

  2021cites this paper
• The Use of Phospholipids to Make Pharmaceutical Form Line Extensions

  2021cites this paper
• Spray-Dried Inhalable Powder Formulations of Therapeutic Proteins and Peptides

  2021cites this paper
• Validation of a diffusion-based single droplet drying model for encapsulation of a viral-vectored vaccine using an acoustic levitator.

  2021cites this paper
• Surface modification strategies for high-dose dry powder inhalers

  2021cites this paper
• Protective effects of aerosolized pulmonary surfactant powder in a model of ventilator-induced lung injury.

  2020cites this paper
• Lecithin-based modified soft agglomerate composite microparticles for inhalable montelukast: Development, tolerability and pharmacodynamic activity

  2020cites this paper
• Overcoming challenges for development of amorphous powders for inhalation

  2020cites this paper
• Contemporary formulation development for inhaled pharmaceuticals.

  2020cites this paper
• Scope and limitations on aerosol drug delivery for the treatment of infectious respiratory diseases.

  2020influential citation
• The Confusing World of Dry Powder Inhalers: It Is All About Inspiratory Pressures, Not Inspiratory Flow Rates

  2020cites this paper
• Spray Drying

  2020cites this paper
• Microparticles

  2020cites this paper
• QbD Approach for Novel Crosslinker-Free Ionotropic Gelation of Risedronate Sodium–Chitosan Nebulizable Microspheres: Optimization and Characterization

  2019cites this paper
• A Design of Experiment (DoE) approach to optimise spray drying process conditions for the production of trehalose/leucine formulations with application in pulmonary delivery.

  2019cites this paper
• Idealhalers Versus Realhalers: Is It Possible to Bypass Deposition in the Upper Respiratory Tract?

  2019cites this paper
• Mesenchymal stem/stromal cell secretome for lung regeneration: The long way through "pharmaceuticalization" for the best formulation.

  2019cites this paper
• Strategies for improving diabetic therapy via alternative administration routes that involve stimuli-responsive insulin-delivering systems.

  2019cites this paper
• Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension.

  2019cites this paper
• Particle interactions in complex dry powder inhaled formulations and single particle aerosol mass spectrometry

  2018cites this paper
• Rapid, Non-destructive Inspection and Classification of Inhalation Blisters Using Low-Energy X-ray Imaging

  2018cites this paper
• Formulation techniques for high dose dry powders

  2018cites this paper
• Towards quantitative prediction of the performance of dry powder inhalers by multi‐scale simulations and experiments

  2018cites this paper
• Preparation and optimization of a dry powder for inhalation of second‐line anti‐tuberculosis drugs

  2018cites this paper
• Inhalable multi‐compartmental phospholipid enveloped lipid core nanocomposites for localized mTOR inhibitor/herbal combined therapy of lung carcinoma

  2018cites this paper
• Dry-powder formulations of non-covalent protein complexes with linear or miktoarm copolymers for pulmonary delivery.

  2018cites this paper
• Immunoglobulin G particles manufacturing by spray drying process for pressurised metered dose inhaler formulations.

  2018cites this paper
• Characterization of matrix embedded formulations for combination spray-dried particles comprising pyrazinamide and rifampicin

  2018cites this paper
• Spray drying for the preparation of innovative nanocoatings and inhalable nanocarriers

  2018cites this paper
• An In Vitro Examination of the Effects of Altitude on Dry Powder Inhaler Performance

  2017cites this paper
• Noninvasive Strategies for Systemic Delivery of Therapeutic Proteins — Prospects and Challenges

  2016cites this paper
• AMANDA ATTOBRAH PREPARATION AND AEROSOLIZATION STUDIES OF FINE POWDERS COMPOSED OF POORLY SOLUBLE DRUGS FOR PULMONARY DRUG DELIVERY

  2016cites this paper
• Spray drying strategies to stop tuberculosis

  2016cites this paper
• Design of inhaled insulin dry powder formulations to bypass deposition in the human extrathoracic region and enhance lung targeting

  2016influential citation
• Amorphous powders for inhalation drug delivery.

  2016cites this paper
• Designing a multi-component spray-dried formulation platform for pulmonary delivery of biopharmaceuticals: The use of polyol, disaccharide, polysaccharide and synthetic polymer to modify solid-state properties for glassy stabilisation

  2016cites this paper
• Decreasing Particle Size of Paclitaxel Using Polymer in Fractional Precipitation Process

  2016cites this paper
• Inhaled anticancer agents

  2016cites this paper
• Formulation Design of Dry Powders for Inhalation.

  2015cites this paper
• Feasibility of highly branched cyclic dextrin as an excipient matrix in dry powder inhalers.

  2015cites this paper
• Pharmaceutical microparticle engineering with electrospraying: the role of mixed solvent systems in particle formation and characteristics

  2015cites this paper
• Amorphous or Crystalline? A Comparison of Particle Engineering Methods and Selection.

  2015cites this paper
• Physical Characterization of Tobramycin Inhalation Powder: I. Rational Design of a Stable Engineered-Particle Formulation for Delivery to the Lungs.

  2015cites this paper
• Spray-Dried Influenza Antigen with Trehalose and Leucine Produces an Aerosolizable Powder Vaccine Formulation that Induces Strong Systemic and Mucosal Immunity after Pulmonary Administration

  2015cites this paper
• Efficacy of a Magnetic Drug Delivery System and Development of an Orthotopic Lung Tumor Imaging Model

  2015cites this paper
• Emerging Nanotechnology Approaches for Pulmonary Delivery of Vaccines

  2014cites this paper
• One-Step Production of Protein-Loaded PLGA Microparticles via Spray Drying Using 3-Fluid Nozzle

  2014cites this paper
• Heat induced evaporative antisolvent nanoprecipitation (HIEAN) of itraconazole.

  2014cites this paper
• Diffusion controlled formation of microparticles

  2014cites this paper
• How can we bring high drug doses to the lung?

  2014cites this paper
• Use of a Fundamental Approach to Spray-Drying Formulation Design to Facilitate the Development of Multi-Component Dry Powder Aerosols for Respiratory Drug Delivery

  2014cites this paper
• Emerging Drying Technologies for Agricultural Products

  2014cites this paper
• Formulation considerations for dry powder inhalers.

  2014cites this paper
• In Vitro Assessment of Dose Delivery Performance of Dry Powders for Inhalation

  2014influential citation
• The PulmoSphere™ platform for pulmonary drug delivery.

  2014cites this paper
• Strategies for Heat‐Stable Vaccines

  2014cites this paper
• Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler

  2014cites this paper
• Manufacturing and Device Options for the Delivery of Biotherapeutics

  2014cites this paper
• Inhaled proteins: challenges and perspectives.

  2013cites this paper
• Pulmonary Delivery of an Ultra-Fine Oxytocin Dry Powder Formulation: Potential for Treatment of Postpartum Haemorrhage in Developing Countries

  2013cites this paper
• Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance.

  2013cites this paper
• The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules.

  2013cites this paper
• Dose Emission Characteristics of Placebo PulmoSphere® Particles Are Unaffected by a Subject's Inhalation Maneuver

  2013cites this paper
• Designing a Multicomponent Spray-Dried Formulation Platform for Pulmonary Delivery of Biomacromolecules: The Effect of Polymers on the Formation of an Amorphous Matrix for Glassy State Stabilization of Biomacromolecules

  2013influential citation
• Improvement of the dispersibility of spray-dried budesonide powders using leucine in an ethanol–water cosolvent system

  2013cites this paper
• Particle engineering technologies for improving the delivery of peptide and protein drugs

  2013cites this paper
• The Development of A New Dry Powder Inhaler

  2013cites this paper
• Methods for understanding, controlling, predicting, and improving drug product performance

  2013cites this paper
• Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations.

  2012cites this paper
• Liquid antisolvent precipitation and stabilization of nanoparticles of poorly water soluble drugs in aqueous suspensions: Recent developments and future perspective

  2012cites this paper
• Peptide and Protein Drug Delivery Systems for Nonparenteral Routes of Administration

  2012cites this paper
• New Respirable and Fast Dissolving Itraconazole Dry Powder Composition for the Treatment of Invasive Pulmonary Aspergillosis

  2012cites this paper
• Drug-lactose binding aspects in adhesive mixtures: controlling performance in dry powder inhaler formulations by altering lactose carrier surfaces.

  2012cites this paper
• Particle engineering for inhalation formulation and delivery of biotherapeutics

  2012cites this paper
• Review on: freeze drying as a crystallization technique

  2011cites this paper